Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease

BACKGROUND: Commonly used neuroimaging biomarkers in Parkinson's disease (PD) are useful for diagnosis but poor at predicting outcomes. We explored whether an atrophy pattern from whole-brain structural MRI, measured in the drug-naïve early stage, could predict PD prognosis. METHODS: 362 de nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeighami, Yashar, Fereshtehnejad, Seyed-Mohammad, Dadar, Mahsa, Collins, D. Louis, Postuma, Ronald B., Dagher, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742805/
https://www.ncbi.nlm.nih.gov/pubmed/31514113
http://dx.doi.org/10.1016/j.nicl.2019.101986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742805/
https://www.ncbi.nlm.nih.gov/pubmed/31514113
http://dx.doi.org/10.1016/j.nicl.2019.101986

Ejemplares similares